Cargando…
Sex Differences in the Level of Homocysteine in Alzheimer’s Disease and Parkinson’s Disease Patients: A Meta-Analysis
Although recent studies suggest homocysteine (Hcy) is an independent risk factor for neurodegenerative disorders, little is known about sex differences in the levels of Hcy. In this study, we conducted a comparative meta-analysis to investigate sex differences in the levels of Hcy in both Alzheimer’...
Autores principales: | Nguyen, V. Phu, Collins, Andrila E., Hickey, Jordan P., Pfeifer, Julia A., Kalisch, Bettina E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856546/ https://www.ncbi.nlm.nih.gov/pubmed/36672134 http://dx.doi.org/10.3390/brainsci13010153 |
Ejemplares similares
-
Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor
por: Nelson, Mackayla L., et al.
Publicado: (2023) -
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
por: Collins, Andrila E., et al.
Publicado: (2022) -
VANL-100 Attenuates Beta-Amyloid-Induced Toxicity in SH-SY5Y Cells
por: Collins, Andrila E., et al.
Publicado: (2022) -
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
por: Bittner, Nadine, et al.
Publicado: (2023) -
Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective?
por: Kocer, Bilge, et al.
Publicado: (2016)